Lucier's long position

Life Technologies Corp. (NASDAQ:LIFE) Chairman and CEO Greg Lucier went on a buying spree after taking the helm at predecessor Invitrogen Corp. in 2003. The strategy appears to have paid off, resulting in a 4x return to any investors who have held shares in the company since then.

Last week, supply and service company Thermo Fisher Scientific Inc. (NYSE:TMO) said it will acquire Life Tech for $76 per share in cash, or $13.6 billion on a fully diluted basis...